Skip to main content

Origins, Distribution, and Risk of Benign Prostatic Hypertrophy

  • Chapter

Abstract

There is no currently available solution, theoretical or empirical, to satisfactorily explain differential population frequencies and individual risk levels of prostatic hypertrophy. Since this is the most prevalent of all pathologic entities in aging males, and virtually all males can expect to develop some hyperplastic foci during the final decades of life, whether or not they result in detectable hypertrophies, it may be moot that the condition is abnormal. That it occurs so universally and is readily treatable, however, does not detract from the observation that it has long been a condition that, with many other maturity-associated setbacks, can be expected to contain the life span of some men. What appears surprising is that mortality from this not-so-benign hypertrophy, despite the development of effective modalities for repair and cure, persists at remarkably high levels in some cultures.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Amaku EO, Da Rocha-Afodu T, Elebute EA: Prostatic obstruction in Nigerians. W Afr Med J 20: 189–194, 1971

    CAS  Google Scholar 

  2. Armenian HK, Lilienfeld AM, Diamond EL, Bross IDJ: Relation between benign prostatic hyperplasia and cancer of the prostate. Lancet 2:115– 117, 1974

    Google Scholar 

  3. Ashley JB: Observations on the epidemiology of prostatic hyperplasia in Wales. Br J Urol 38: 567–569, 1966

    Article  PubMed  CAS  Google Scholar 

  4. Bourke JB, Griffin JP: Blood groups in benign and malignant prostatic hypertrophy. Lancet 2: 1279–1280, 1962

    Article  PubMed  CAS  Google Scholar 

  5. Bourke JB, Griffin JP: Hypertension, diabetes mellitus and blood groups in benign prostatic hypertrophy. Br J Urol 38: 18–23, 1966

    Article  PubMed  CAS  Google Scholar 

  6. Bourke JB, Griffin JP: Diabetes mellitus in patients with benign prostatic hyperplasia. Br Med J 4:492– 493, 1968

    Article  PubMed  CAS  Google Scholar 

  7. D’Aunoy R, Schenken JR, Burns EL: The relative incidence of hyperplasia of the prostate in the white and colored races of Louisiana. South Med J 32: 47–52, 1939

    Article  Google Scholar 

  8. Derbes VDP, Leche SM, Hooker CW: The incidence of benign prostatic hypertrophy among the whites and negroes in New Orleans. J Urol 38:383– 388, 1937

    Google Scholar 

  9. Dodge OG: Carcinoma of the prostate in Uganda Africans. Cancer 16: 1264–1268, 1963

    Article  PubMed  CAS  Google Scholar 

  10. Finkle AL: The relationship of sexual habits to benign prostatic hypertrophy. Med Aspects Hum Sexualr 1: 24–25, 1967

    Google Scholar 

  11. Greenwald P, Kirmss V, Polan AK, Dick VS: Cancer of the prostate among men with benign prostatic hyperplasia. J Natl Cancer Inst 53: 335–340, 1974

    PubMed  CAS  Google Scholar 

  12. Haugen OA: Discussion. In Grayhack JT, Wilson JD, Sherbenske MJ (eds.): Benign Prostatic Hyperplasia. DHEW Publ. No. (NIH)76–1113, US Gov’t Printing Office, Washington, DC, 1976, p 117

    Google Scholar 

  13. Hechter O: Reflections on the NIH workshop on BPH. In Grayhack JT, Wilson JD, Sherbenske21 Origins, Distribution, and Risk MJ (eds): Benign Prostatic Hyperplasia. DHEW Publ. No. (NIH)76-1113, US Gov’t Printing Office, Washington, DC, 1976, pp 269–281

    Google Scholar 

  14. Houston W: The Bantu prostate: a study of prostatic disease in central Africa. J Urol 99: 316–320, 1968

    PubMed  CAS  Google Scholar 

  15. Ismail AAA, Harkness RA: Urinary testosterone excretion in men in normal and pathological conditions. Acta Endocrinol (Copenh) 56: 469–480, 1967

    CAS  Google Scholar 

  16. Kambal A: Prostatic obstruction in Sudan. J Urol 49: 139–141, 1977

    Article  CAS  Google Scholar 

  17. Lissoos I: Simple prostatic hyperplasia in the Bantu. S Afr Med J 47: 389–391, 1973

    PubMed  CAS  Google Scholar 

  18. Moore RA: Benign hypertrophy of the prostate: a morphological study. J Urol 50: 680–710, 1943

    Google Scholar 

  19. Moore RA: Benign hypertrophy and carcinoma of the prostate. Surgery 16: 152–167, 1944

    Google Scholar 

  20. Odunjo EO, Elebute EA: Chronic prostatitis in BPH. Br J Urol 43: 333–336, 1971

    Article  PubMed  CAS  Google Scholar 

  21. Pond DA, Maratos J: Psychosocial inter-relations of benign prostatic hypertrophy. J Psychosom Res 21: 201–206, 1976

    Article  Google Scholar 

  22. Richardson IM: Prostatic cancer and social class. Br J Prev Soc Med 19: 140–142, 1965

    PubMed  CAS  Google Scholar 

  23. Roberts HJ: The role of diabetogenic hyperinsulinism in the pathogenesis of prostatic hyperplasia and malignancy. J Am Geriatr Soc 14: 795–825, 1966

    PubMed  CAS  Google Scholar 

  24. Robson MC: The incidence of benign prostatic hypertrophy and prostatic carcinoma in cirrhosis of the liver. J Urol 92: 307–310, 1964

    PubMed  CAS  Google Scholar 

  25. Rotkin ID: Epidemiology of benign prostatic hypertrophy: review and speculations. In Grayhack JT, Wilson JD, Sherbenske MJ (eds.): Benign Pros¬tatic Hyperplasia. DHEW Publ. No. (NIH)76-1113, US Gov’t Printing Office, Washington, DC, 1976, pp 105–117

    Google Scholar 

  26. Siiteri PK, Wilson JD: Dihydrotestosterone in prostatic hypertrophy. J Clin Invest 49: 1737–1745, 1970

    Article  PubMed  CAS  Google Scholar 

  27. Tveter KJ: Some aspects of the pathogenesis of prostatic hyperplasia. Acta Pathol Microbiol Scand [A] (Suppl) 248: 167–174, 1974

    Google Scholar 

  28. Van der Reis L: Benign prostatic hypertrophy and coronary heart disease: correlation of coincidence? J Am Geriatr Soc 7: 866–869, 1959

    Google Scholar 

  29. Whitmore WF Jr: The natural history of prostatic cancer. Cancer 32: 1104–1112, 1973

    Article  PubMed  Google Scholar 

  30. Whitmore WF III: Benign prostatic hyperplasia; widespread and sometimes worrisome. Geriatrics 36: 119–136, 1981

    PubMed  Google Scholar 

  31. Wilson JD: The pathogenesis of benign prostatic hyperplasia. Am J Med 68: 745–756, 1980

    Article  PubMed  CAS  Google Scholar 

  32. World Health Statistics Annual: Vital Statistics and Causes of Death, Vol 1. World Health Organization, Geneva, 1980.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag New York Inc.

About this chapter

Cite this chapter

Rotkin, I.D. (1983). Origins, Distribution, and Risk of Benign Prostatic Hypertrophy. In: Hinman, F., Boyarsky, S. (eds) Benign Prostatic Hypertrophy. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-5476-8_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-5476-8_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-5478-2

  • Online ISBN: 978-1-4612-5476-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics